ImageneBio, Inc.
- Last sale
- Nov 12, 2026 · -5.99%
- Market cap
- $44.97M
- 12.46M shares
- Filings
- 339
FY 2025−77.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2023derivedN/M FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026+680.1% FY25 yoy
- $44.97M
- —
- 56.2×
- 0.4×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $800,000 | reported | |
| FY 2024 | 2024-12-31 | $3,500,000 | reported | |
| FY 2023 | 2023-12-31 | $9,160,000 | reported | |
| FY 2022 | 2022-12-31 | $15,618,000 | reported | |
| FY 2021 | 2021-12-31 | $30,985,000 | reported | |
| FY 2020 | 2020-12-31 | $9,194,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $663.00K | $663.00K | — | 48.26M sh | +33.1% | — |
Biological products, except diagnostic substances
ImageneBio, Inc. is the 81st largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
ALGSAligos Therapeutics, Inc.$2.2M39.5%1,106.7%$12.6MHUMAHumacyte, Inc.$2.0M—2,003.6%$165.5MOTLKOutlook Therapeutics, Inc.$1.4M—4,416.2%$107.1MSCNIScinai Immunotherapeutics Ltd.$1.3M99.2%633.6%$1.6MINBXInhibrx Biosciences, Inc.$1.3M550.0%10,773.5%$1.3BPLURPluri Inc.$1.0M24.0%2,344.6%$17.3MPROKProkidney Corp.$893.0K1,075.0%7,725.2%$347.7M
IMAImageneBio, Inc. (this company)$800.0K77.1%5,668.6%$45.0M
CRDFCardiff Oncology, Inc.$593.0K13.2%7,732.0%$56.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR